Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Antibody”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00936143
What this trial is testing

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Who this might be right for
Spondylitis
Gu Jieruo 70
Testing effectiveness (Phase 2)Looking for participantsNCT07493317
What this trial is testing

Neutralizing Interleukin (IL)-6

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 60
Early research (Phase 1)Study completedNCT03939026
What this trial is testing

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Who this might be right for
Relapsed/Refractory Large B Cell LymphomaRelapsed/Refractory Follicular Lymphoma
Allogene Therapeutics 50
Early research (Phase 1)UnknownNCT04755543
What this trial is testing

LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms

Who this might be right for
Digestive System Neoplasms
Taizhou HoudeAoke Biomedical Co., Ltd. 94
Testing effectiveness (Phase 2)Study completedNCT01426789
What this trial is testing

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 100
Early research (Phase 1)Ended earlyNCT01279291
What this trial is testing

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Who this might be right for
NeoplasmsOvarian NeoplasmsFallopian Tube Neoplasms+1 more
Kyowa Kirin Co., Ltd. 22
Early research (Phase 1)UnknownNCT04756934
What this trial is testing

HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Who this might be right for
Melanoma
Taizhou HoudeAoke Biomedical Co., Ltd. 63
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Early research (Phase 1)Study completedNCT00091806
What this trial is testing

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

Who this might be right for
TumorsOncologySolid Tumors
Amgen 86
Early research (Phase 1)Study completedNCT05505448
What this trial is testing

A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Who this might be right for
Healthy
Regeneron Pharmaceuticals 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469306
What this trial is testing

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fujian Cancer Hospital 130
Testing effectiveness (Phase 2)Study completedNCT02000817
What this trial is testing

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Ended earlyNCT03769181
What this trial is testing

Isatuximab-based Therapy in Participants With Lymphoma

Who this might be right for
Lymphoma
Sanofi 58
Large-scale testing (Phase 3)Study completedNCT04063163
What this trial is testing

A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 585
Not applicableActive Not RecruitingNCT06865521
What this trial is testing

Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer

Who this might be right for
Colo-rectal CancerPD-1 InhibitorAkkermansia Muciniphila
West China Hospital 22
Testing effectiveness (Phase 2)Study completedNCT01585233
What this trial is testing

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Global Development, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT02574598
What this trial is testing

MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Instituto Nacional de Cancerologia de Mexico 78
Testing effectiveness (Phase 2)Looking for participantsNCT06669247
What this trial is testing

Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals 186
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04825938
What this trial is testing

Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

Who this might be right for
Salivary Gland Malignant NeoplasmsSalivary Gland Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 15
Testing effectiveness (Phase 2)Study completedNCT00060138
What this trial is testing

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
Chugai Pharmaceutical
Next Page